Article
KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C.
American journal of kidney diseases : the official journal of the National Kidney Foundation - 1 May 2020
Roth David, Bloom Roy D, Molnar Miklos Z, Reese Peter P, Sawinski Deirdre, Sise Meghan E, Terrault Norah A
Abstract excerpt
The first KDIGO (Kidney Disease: Improving Global Outcomes) guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection was published in 2008. The ensuing decade bore witness to remarkable advances in the treatment of HCV infection following the approval of direct-acting antiviral (DAA) agents that deliver cure rates routinely >95%. In this context, the KDIGO...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
